Skip to content

Effect of Virtual Reality Glasses on Pain, Anxiety, and Comfort During Extracorporeal Shock Wave Lithotripsy

Investigation of the Effect of Virtual Reality Glasses Used During Extracorporeal Shock Wave Lithotripsy (ESWL) on Patients' Pain, Anxiety, and Comfort Levels: A Randomized Controlled

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06804928
Acronym
ESWL
Enrollment
70
Registered
2025-02-03
Start date
2025-02-01
Completion date
2025-09-01
Last updated
2026-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Comfort, ESWL, Pain, Virtual Reality

Brief summary

Effect of Virtual Reality Glasses on Pain, Anxiety, and Comfort During ESWL

Interventions

BEHAVIORALVirtual Reality Glasses

During the procedure, the patient will wear virtual reality glasses and watch a video. The video will be played through the virtual reality glasses throughout the entire procedure.

Sponsors

Akdeniz University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

The measurements will be conducted by an individual independent of the study. Additionally, the statistical analysis of the research will be performed by a statistician who is unaware of the study details. The randomization plan was also prepared by a researcher independent of the study.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* being 18 years of age or older, * scheduled for elective ESWL due to renal or ureteral calculi, * being conscious and able to communicate, * voluntarily participated in the study after providing written informed consent, * absence of coagulopathy or bleeding disorders, * having a single radiopaque renal or ureteral calculus measuring ≤ 10 mm in diameter.

Exclusion criteria

* visual or auditory impairments preventing the use of virtual reality glasses, * psychiatric or neurological disorders that could interfere with perception of the intervention, * a diagnosis of epilepsy, * the presence of multiple renal or ureteral calculi, * abdominal arterial aneurysm, urinary diversion or urinary obstruction, * the use of any sedatives or anxiolytics before or during the procedure.

Design outcomes

Primary

MeasureTime frameDescription
VASData will be collected 10 minutes before the procedure.Pain levels will be assessed.
Visual Anxiety Scale (VAS-A)Data will be collected 10 minutes before the procedure.Anxiety levels will be assessed.
Visual Comfort ScaleData will be collected 10 minutes before the procedure.Comfort levels will be assessed.
Spielberger Trait Anxiety Inventory (STAI-II)The measurement will be conducted only once, 10 minutes before the procedure.It will be used to measure trait anxiety levels before the procedure.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 19, 2026